Rchr
J-GLOBAL ID:200901048872191080   Update date: Mar. 30, 2024

Nishida Naoshi

ニシダ ナオシ | Nishida Naoshi
Affiliation and department:
Homepage URL  (1): http://www.med.kindai.ac.jp/shoukaki/index.html
Research field  (3): Biological, health, and medical informatics ,  Genomics ,  Gastroenterology
Research keywords  (9): data base ,  artificial Intelligence ,  Molecular Biology ,  Hepatology ,  Gastroenterology ,  Epigenetics ,  chromosome ,  tumor suppressor gene ,  Hepatocellular carcinoma
Research theme for competitive and other funds  (35):
  • 2024 - 2027 胆道癌のドライバー変異に着目した腫瘍免疫微小環境の再構築と治療最適化
  • 2022 - 2025 免疫チェックポイント阻害剤投与に伴う急速な腫瘍増大(HPD)の発症機序の解析
  • 2021 - 2024 Analysis of immunological microenvironment of tumor and effect of smoking habits for the development of personalized medicine in liver cancer
  • 2021 - 2024 Development of AI-aided US diagnosis system for liver tumor
  • 2021 - 2024 Identification of resistant clone for the chemotherapy of hepatocellular carcinoma using cell free DNA
Show all
Papers (313):
  • Margherita Rimini, Bernardo Stefanini, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Fabian Finkelmeier, Changhoon Yoo, José Presa, Elisabeth Amadeo, et al. Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab. Liver international : official journal of the International Association for the Study of the Liver. 2024
  • Satoru Hagiwara, Toru Takase, Itsuki Oda, Yoriaki Komeda, Naoshi Nishida, Akihiro Yoshida, Tomoki Yamamoto, Takuya Matsubara, Masatoshi Kudo. Hereditary hemorrhagic telangiectasia with hepatic arteriovenous shunt diagnosed due to liver damage. Clinical Journal of Gastroenterology. 2024
  • Lorenz Balcar, Bernhard Scheiner, Claudia Angela Maria Fulgenzi, Antonio D'Alessio, Katharina Pomej, Marta Bofill Roig, Elias Laurin Meyer, Jaekyung Che, Naoshi Nishida, Pei-Chang Lee, et al. A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma. JHEP reports : innovation in hepatology. 2024. 6. 2. 100982-100982
  • Tomoko Aoki, Masatoshi Kudo, Kazuomi Ueshima, Masahiro Morita, Hirokazu Chishina, Masahiro Takita, Satoru Hagiwara, Hiroshi Ida, Yasunori Minami, Masakatsu Tsurusaki, et al. Incidence of Hyper Progressive Disease in Combination Immunotherapy and Anti-Programmed Cell Death Protein 1/Programmed Death-Ligand 1 Monotherapy for Unresectable Hepatocellular Carcinoma. Liver cancer. 2024. 13. 1. 56-69
  • Silvia Camera, Margherita Rimini, Federico Rossari, Toshifumi Tada, Goki Suda, Shigeo Shimose, Masatoshi Kudo, Changhoon Yoo, Jaekyung Cheon, Fabian Finkelmeier, et al. Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular Carcinoma. Targeted oncology. 2024. 19. 1. 29-39
more...
MISC (348):
  • 西田 直生志. AIを基盤とした超音波検査の未来像 肝腫瘤診断における新たな可能性と展望. 日本がん検診・診断学会誌. 2023. 31. 1. 98-98
  • 萩原 智, 西田 直生志, 工藤 正俊. B型肝炎診療の未来予想図(現状と課題) 免疫チェックポイント阻害剤投与に伴うHBV再活性化および抗ウイルス効果についての検討. 肝臓. 2023. 64. Suppl.1. A51-A51
  • 萩原 智, 西田 直生志, 工藤 正俊. 遺伝・代謝性肝疾患の未来予想図(現状と課題) Erythropoietic porphyria(EPP)関連肝障害における瀉血治療の有効性. 肝臓. 2023. 64. Suppl.1. A111-A111
  • 萩原 智, 西田 直生志, 工藤 正俊. NASH/ASHの病態解明とTransrational Research 非アルコール性脂肪肝疾患におけるDNAメチル化に関連する臨床的・病理学的特徴. 肝臓. 2023. 64. Suppl.1. A208-A208
  • 有山 武尊, 萩原 智, 西田 直生志, 工藤 正俊. 非硬変肝から発生したFontan術後HCCの1例. 肝臓. 2023. 64. Suppl.1. A324-A324
more...
Books (22):
  • Immunotherapy in Hepatocellular Carcinoma
    MDPI Books 2023 ISBN:9783036566917
  • Treatment of HCC using Atezolizumab+Bevacizumab
    2021
  • AI diagnosis for Ultrasonography
    2021 ISBN:9784274225765
  • US diagnosis for Ultrasonography
    2021 ISBN:9784274225765
  • US diagnosis for Ultrasonography
    2021 ISBN:9784274225765
more...
Lectures and oral presentations  (493):
  • Development and Prospects of AI-aided Ultrasonography (US) System - New Possibilities in Diagnosis of Liver Tumor -
    (The 33rd Annual Meeting of APASL (Asian Pacific Association for Study of the Liver): Bridging Clinical and Basic Research 2024)
  • The roles of angiogenesis inhibitors and immune checkpoint inhibitors in the treatment of liver cancer.
    (2024)
  • AI支援による超音波検査システムの開発と展望 -肝腫瘤診断における新たな可能性-
    (第42回東海超音波研究会 特別講演 2024)
  • Non-inflamed typeの胆管癌における 抗原提示分子のメチル化と発現低下
    (第45回日本肝臓学会西部会:ワークショップ3 予後改善に向けた胆管癌の集学的治療 2023)
  • 切除不能HCCに対するABC conversion療法とclinical CRの現状
    (第45回日本肝臓学会西部会: ワークショップ1 肝がん局所療法の多様性とその到達点 2023)
more...
Education (2):
  • - 1993 Kyoto University Graduate School of Medicine
  • - 1985 Osaka Medical College Faculty of Medicine Division of Medicine
Professional career (1):
  • M.D, Ph.D. (Kyoto University Graduate School of Medicine)
Work history (6):
  • 2021/04 - 現在 Kindai University Faculty of Medicine Professor
  • 2011/08 - 2021/03 Fuculty of Medicine Kindai University Department of Gastroenterology and Hepatology Associate Professor
  • 2006/08 - 2011/07 Kyoto University Graduate School of Medicine Department of Gastroenterology and Hepatology Assistant Professor/Lecture
  • 2004/02 - 2006/07 Baylor University Medical Center Division of Gastroenterology Reserach Associate
  • 1997/04 - 2004/01 Kyoto University Graduate School of Medicine Department of Medicine and Clinical Science Assistant Professor
Show all
Committee career (16):
  • 2023/12 - 現在 Swiss National Science Foundation (SNSF) External Reviewer
  • 2022/11 - 現在 JSUM health committee member
  • 2022/04 - 現在 The Japan Society of Hepatology Member of COI committee
  • 2020/04 - 現在 Japan Society of Hepatology Movement for Fight against Liver Cancer, Person in Charge, Osaka Prefecture
  • 2020/04 - 現在 The Japan Society of Ultrasonics in Medicine Committee member for construction of US image database and development of US-AI
Show all
Awards (19):
  • 2022/06 - The Japan Society of Hepatology Hepatology Research Citation Award Immune checkpoint blockade for the treatment of human hepatocellular carcinoma
  • 2021/04 - Smoking Resarch Foundation Research Grant Analysis of immunological microenvironment of liver cancer
  • 2020/04 - National Institute of Informatics ROIS NII Open Collaborative Research 2020 Artificial intelligence for prediction of outcome after chemotherapy in patients with hepatocellular carcinoma
  • 2017/04 - 公益財団法人喫煙科学研究財団 一般研究助成
  • 2012/06 - 財団法人ひと・健康・未来研究財団 研究助成(医学分野)
Show all
Association Membership(s) (10):
米国消化器病学会 ,  日本高齢消化器病学会 ,  THE JAPAN SOCIETY FOR CLINICAL IMMUNOLOGY ,  THE JAPAN SOCIETY OF ULTRASONICS IN MEDICINE ,  JAPAN GASTROENTEROLOGICAL ENDOSCOPY SOCIETY ,  日本分子生物学会 ,  日本癌学会 ,  日本消化器病学会 ,  日本肝臓学会 ,  日本内科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page